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In most colorectal tumours, APC mutation stabilises b-catenin and mimics elements of Wnt growth factor signalling, but the high
frequency of epigenetic loss of Wnt antagonists indicates an additional role for ligand-mediated Wnt signalling. Here, we have
investigated the expression of key components of b-catenin-independent Wnt response pathways to determine whether their
profiles change during the transition from normal mucosa to colorectal adenomas. Transcription of the Wnt/planar cell polarity
pathway determinant NKD1 (naked cuticle homologue 1) was induced in adenomas by a median 135-fold and in cancers by 7.4-fold.
While some Frizzleds (FZDs) were downregulated in adenomas, the Wnt/Ca
2þ receptors FZD3 and FZD6 were induced by a
median factor of 6.5 and 4.6, respectively. Naked cuticle homologue 1, FZD3 and FZD6 expression were coordinated in
pre-malignant disease, but this relationship was lost in invasive cancers, where FZD induction was seen less frequently. Naked cuticle
homologue 1 expression was associated with nuclear localisation of phospho-c-Jun in adenomas. In cultured cells, NKD1 transcription
was induced by lithium chloride but FZD3 expression required Wnt growth factor treatment. These data show that Wnt responses
are consistently directed towards both b-catenin-independent routes in early colorectal tumorigenesis and elements of this are
retained in more advanced cancers. These b-catenin-independent Wnt signalling pathways may provide novel targets for
chemoprevention of early colorectal tumours.
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Our studies (Caldwell et al, 2004, 2006) and those of others (Suzuki
et al, 2004) have established that Wnt antagonists are down-
regulated at the earliest stages of colorectal tumorigenesis,
presenting the neoplastic cells with an environment where Wnt
growth factor signals are unmodulated. These data indicate a
potential role for Wnt growth factor signalling in tumorigenesis
and this is supported by the sensitivity of tumour cells
to exogenous antagonists of Wnt—Frizzled (FZD) interaction
(DeAlmeida et al, 2007).
Wnt growth factors have been shown to influence b-catenin
activity, when normal controls have been lost through b-catenin
mutation as occurs sometimes in colorectal cancer (Suzuki et al,
2004), but do not appear to influence this pathway in the presence
of APC mutations (DeAlmeida et al, 2007), which are more
common in genetic and sporadic disease. Wnts can, however, also
provoke responses through alternative, b-catenin-independent,
signalling pathways. Of these, the Wnt/planar cell polarity (Wnt/
PCP) pathway (Boutros et al, 1998) employs the same FZD
receptors as the b-catenin pathway, the signal being diverted
within the cell by the action of naked cuticle homologue 1 (NKD1)
(Yan et al, 2001), resulting in activation of Jun N-terminal kinase
(JNK) and RhoA, while the Wnt/calcium (Wnt/Ca
2þ) pathway is
more difficult to define, particularly in non-embryonic tissues. It
may employ a distinct subset of FZDs, notably FZD3, FZD4 and
FZD6 (Sheldahl et al, 1999), and can lead to a rise in cytosolic
calcium levels (Sheldahl et al, 1999) and/or antagonism of
b-catenin action (Mikels and Nusse, 2006).
The central role of b-catenin driven transcription in colorectal
tumorigenesis has been firmly established, but the contributions
of the alternative Wnt pathways have not been explored. Recently,
c-Jun has been shown to be important in bowel adenoma
formation and to cooperate with b-catenin in promoting
TCF4-dependent transcription (Nateri et al, 2005; Toualbi et al,
2007), implying a role for the Wnt/PCP pathway, although the
potential for Wnt/Ca
2þ signalling to participate is less clear. One
of its known outcomes is suppression of b-catenin action (Mikels
and Nusse, 2006), but it is possible that chronic activation of this
pathway might have other effects in neoplasia. In non-small cell
lung cancer, expression of one of the Wnt/Ca
2þ pathway’s ligands,
Wnt5a, has been associated with disease progression (Huang et al,
2005). This has also been reported in gastric cancer (Kurayoshi
et al, 2006) and pancreatic cancer (Ripka et al, 2007). It may,
however, act as a tumour suppressor in other cases (Liang et al,
2003; Blanc et al, 2005; Dejmek et al, 2005; Kremenevskaja et al,
2005), suggesting that Wnt/Ca
2þ signalling can have a variable
role in different tumour settings.
In normal cells, both the Wnt/PCP and Wnt/Ca
2þ pathways
participate in homoeostatic responses to Wnt/b-catenin signalling,
by diverting the signal downstream of the receptor and by
antagonising b-catenin/TCF4 transcription. We hypothesised that
the chronic state of b-catenin activation in colorectal tumour cells
might, therefore, lead to a sustained increase in expression of these
alternative Wnt-response pathways, which, in the absence of
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(sFRP1) (Caldwell et al, 2004, 2006), would be highly sensitive to
Wnt growth factor signalling and this may contribute to
tumorigenesis. Naked cuticle homologue 1 is central to the Wnt/
PCP pathway and has previously been shown to be expressed in
advanced colorectal cancers (Yan et al, 2001) and to be induced by
the Wnt/b-catenin pathway (Caldwell et al, 2006), but its
expression in premalignant adenomas has not been investigated.
Similarly, expression changes in the FZDs, particularly FZDs 3, 4
and 6 as determinants of a Wnt/Ca
2þ response, have not been
measured in colorectal adenomas or cancers.
In this paper, we show that NKD1, FZD3 and FZD6 transcripts
are all induced significantly in colorectal adenomas compared to
matched normal tissue, indicating that both the Wnt/PCP and the
Wnt/Ca
2þ-response pathways are expressed at an early stage in
tumour formation. These inductions are coordinated in adenomas
and correlate with b-catenin stabilisation and nuclear accumula-
tion of phospho-c-Jun. Stabilisation of b-catenin in cultured cells
using lithium chloride induced NKD1 (Wnt/PCP pathway)
expression but had no effect on FZD3 (Wnt/Ca
2þ pathway) levels,
while Wnt3a conditioned medium caused induction of both
targets, indicating that b-catenin is responsible for some but not
all of the changes seen in adenomas.
These data show that b-catenin stabilisation is sufficient to
induce Wnt/PCP components but that a Wnt signal is required to
induce expression of the Wnt/Ca
2þ receptors, indicating that the
expression profile of Wnt/Ca
2þ receptors seen in adenomas
requires b-catenin-independent signalling.
MATERIALS AND METHODS
Sample collection
Adenoma and carcinoma samples were obtained with individual
patient consent, following the local ethics committee guidelines for
resected specimens. Separate ethical approval was given for
analysis of paraffin blocks (LREC No. 2003/277).
All adenomas were from the rectum and sigmoid colon. The 14
matched samples were from patients with a median age 63 years
(range 56–65 years), and included five adenomas less than 10mm
in diameter, five tubular adenomas and nine tubulovillous lesions.
Unmatched polyps included six adenomas under 10mm in size,
two were simple tubular lesions and the median age was 61 years.
The unmatched normal tissue was from patients with a median age
of 63 years (range 60–65 years).
Eighteen primary colorectal cancers were collected with
matched normal mucosal samples. The median age of the cohort
was 74 years (range 43–91 years). In 10 cases, the primary cancer
was at the splenic flexure or proximal colon, and 3 were rectal
cancers. Six cancers had lymph node metastases at the time of
diagnosis, and two had liver metastases.
RNA extraction and reverse transcription
Total RNA was extracted using TRI reagent (Sigma, Poole, UK)
according to the manufacturer’s instructions. First-strand cDNA
was synthesised from 2mg of DNase-treated total RNA using
Ready-To-Go You-Prime First-Strand Beads (Amersham Pharmacia
Biotech, Chalfont, St Giles, UK) and random hexamers (Promega,
Southampton, UK).
Qualitative RT–PCR
Oligonucleotide primers to amplify NKD1 and FZDs 3, 4, 6 and 10
were designed using Primer3 software (Rozen and Skaletsky, 1996)
and synthesised by Alta Biosciences (University of Birmingham,
Birmingham, UK). Details of these are given in Table 1. Where
possible, amplicons were designed to span an exon/intron
boundary. Oligonucleotides for FZDs1, 2 and 8 were as previously
published (Kirikoshi et al, 2001). All reactions were prepared to a
final volume of 25ml, containing 1  BIOTAQ NH4-based reaction
buffer (BIOLINE, London, UK), 1mM Mg2Cl, 2mM dNTPs
(Amersham Pharmacia Biotech), 250ng of each primer, 0.5U of
BIOTAQ DNA polymerase (BIOLINE) and 1ml of cDNA. Ampli-
fication involved an initial step of 2min at 941C, followed by 35
cycles of 941C for 10s, 581C for 20s and 721C for 30s, with a final
extension of 5min at 721C.
Quantitative real-time PCR
Oligonucleotide primers and TaqMan probes (Table 1) were
designed using Primer Expresst, version 1.5 (PE Applied
Biosystems, Warrington, UK). TaqMan Universal PCR Master
Mix and TaqMan probes were purchased from PE Applied
Biosystems. Multiplex PCR amplifications were performed using
an ABI PRISM 7700 Sequence Detector in a final volume of 25ml.
Table 1 Sequences of primers used in RT–PCR and real-time RT–PCR analysis
Primers TaqMan probe
Conventional RT–PCR
NKD1 (NM_033119) F, 50-CGCCGGGATAGAAAACTACA-30
R, 50-CTGGAGCTCTGAGACCTTGG-30
FZD3 (NM_017412) F, 50-ACATCCACCCATGCTTCTTC-30
R, 50-TCGTGACTGTTCATTGAGCC-30
FZD4 (NM_012193) F, 50-CCAACATGGCTGTTGAAATG-30
R, 50-GTCTCACTGCCTTTTCCAGG-30
FZD6 (NM_003506) F, 50-ATGAGAGAGGTGAAAGCGGA-30
R, 50-TTGGTTCTGAAGAACTGGGG-30
FZD10 (NM_007197) F, 50-CCTCCAAGACTCTGCAGTCC-30
R, 50-GACTGGGCAGGGATCTCATA-30
Real-time PCR
NKD1 (NM_033119) F, 50-TCGCCGGGATAGAAAACTACA-30 P, 50-CCAATTTGGGCCTGGCTCCCC-30
R, 50-CAGTTCTGACTTCTGGGCCAC-30
FZD3 (NM_017412) F, 50-CATGGAGATGTTTGGTGTTCCTT-30 P, 50-TCTGGGAACCTACTGCATTCCATATCTTCAGG-30
R, 50-AAGTCGAGGATATGGCTCATCAC-30
KRT8 (NM_002273) F, 50-GATCGCCACCTACAGGAAGCT-30 P, 50-CCGGCTCTCCTCGCCCTCCA-30
R, 50-ACTCATGTTCTGCATCCCAGACT-30
FZD6 (NM_003506) F, 50-ATCTGATGGGTCATTATGACCAGAGT-30
R, 50- TTTGCGAGAGGAAGAAAATGCT-30
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Master Mix (PE Applied Biosystems), 90nM keratin 8 (KRT8) and
target gene primers, 150nM target gene TaqMan probe, 175nM
KRT8 TaqMan probe and 1ml of cDNA. Cycling conditions were an
initial step at 501C for 2min and 951C for 10min, followed by 40
cycles at 951C for15s and 601C for 1min. Results from the target
genes were normalised to the epithelial cell-specific gene KRT8 as
described previously (Caldwell et al, 2004). The expression levels
of KRT8 were consistent between adenoma (median Ct
value¼22.40, IQR 20.3–23.2) and normal samples (median Ct
value¼22.39, IQR 21.8–23.8).
Immunohistochemistry
The Streptavidin–biotin indirect immunoperoxidase method was
performed as described previously (Hardy et al, 2002). Sections
(5mm) were dewaxed, rehydrated and endogenous peroxidase
activity blocked by incubation in 10% H2O2 in methanol for
10min. Microwave antigen retrieval was undertaken for 1h.
Sections were incubated overnight with primary antibodies
recognising b-catenin (clone 14, Transduction Laboratories,
Cowley, UK) or phospho-c-Jun (ser63-P, Santa Cruz Biotechnol-
ogy, Heidelberg, Germany) at a dilution of 1:300. After washing
with PBS, sections were incubated with biotinylated goat anti-
mouse/rabbit IgG (Dako, Ely, UK) according to the manufacturer’s
instructions for 30min. Serial PBS washing and incubation
with streptavidin-peroxidase conjugate (Dako) was undertaken
prior to incubation with diaminobenzidine tetrahydrochloride
(Sigma). Sections were counterstained with haematoxylin (BDH),
dehydrated and analysed on a light microscope.
Lithium and Wnt3a treatment of cultured cells
The normal small intestine epithelial cell line FHs74Int (ATCC,
LGC Promochem, Teddington, UK) was cultured using Hybri-Care
medium (ATCC) supplemented with 1.5gl
 1 sodium bicarbonate
and 10% foetal calf serum. Cells were grown in 6cm dishes and
treated with 10mM LiCl or 10mM KCl as a control. Cells were
harvested over a time course of 16h and RNA, DNA and protein
were extracted using TRI reagent (Sigma).
Wnt3a conditioned medium was produced from mouse L-cells
(ATCC) stably expressing the recombinant protein and used to
treat HeLa cells. Parallel experiments were performed with
medium conditioned by the parental L-cells to exclude the effects
of other secreted activities.
Where appropriate, statistical analysis was performed using
Fishers exact test.
RESULTS
RT–PCR analysis of colorectal adenomas
We devised conventional RT–PCR assays for NKD1 and each of
the human FZD sequences and used these to analyse RNA
extracted from a series of adenomas and control normal mucosa
samples. Figure 1 shows the results of this analysis for NKD1 on a
series of 14 adenomas. Of these, the majority (12 out of 14) of
adenomas expressed NKD1, but this was detected in only three of
the matched normal controls (P¼0.001).
Significant changes were also apparent in the analyses
performed on a series of 19 adenomas for the FZDs, and these
are summarised in Table 2 (primary data not shown). While the
frequency of FZDs 1, 5 and 7 expression appeared unchanged
between normal and adenoma RNA, FZDs 2 and 8 were expressed
much less often in the adenomas (P¼0.003 and 0.007 respec-
tively). Frizzleds 4, 6 and 10 showed less obvious changes, with a
tendency to become expressed in the adenomas, the increased
incidence of FZD6 just reaching significance (Po0.04). The most
striking change found, however, was that for the Wnt/Ca
2þ
receptor FZD3, which was expressed in 13 of 19 adenomas, but
only in 2 of 13 normal tissues (P¼0.005).
Real-time RT–PCR analysis
Since the qualitative review of expression indicated induction of
NKD1, FZD3 and FZD6 in colorectal adenomas, we developed
quantitative real-time RT–PCR assays for each of these to
determine the extent of the induction. Transcript levels were
compared with levels of KRT8, an epithelial cell-specific marker, to
control for the variation in stromal and inflammatory cell
components between dysplastic and normal epithelium (Caldwell
et al, 2004, 2006). Performing these experiments for NKD1
revealed substantial induction in all but 2 of 14 adenomas,
compared with normal mucosa. In two-thirds (9 out of 14) of
cases, NKD1 was upregulated by a factor of more than 50-fold, and
in half (7 out of 14), the induction was in excess of 100-fold, while
the median level of induction over the whole group was 135-fold
(Figure 2).
Frizzleds 3 and 6 were also induced in most adenomas, with a
median of 6.5- and 4.6-fold, respectively. Frizzled 3 was induced in
11 of 14 adenomas by a factor of 1.5–31. Frizzled 6 was measured
in a subset of 12 of the 14 adenomas and was found to be induced
in 10 of these.
These data show upregulation of key components of both the
Wnt/PCP and the Wnt/Ca
2þ pathways compared to normal
epithelium.
N  A N  A N  A N  A N  A N  A N  A N  A N  A N  A N  A N  A N  A N  A + – MW
1 2 34 56789 1 0 1 1 1 2 1 3 1 4
Figure 1 RT–PCR detection of NKD1 in colorectal adenomas. cDNA prepared from 14 matched normal/adenoma pairs (N and A, respectively) was
amplified using primers specific for NKD1 together with a positive control (þ) and a sample with no cDNA ( ) and analysed by agarose gel
electrophoresis. Products can be observed in all adenoma tracks except for samples 6 and 11 but are absent from the normal samples except for 2, 4 and 5.
Table 2 Summary of RT–PCR results for FZD expression in matched
and unmatched adenomas (A) and normal (N) mucosa
Matched Unmatched Total (%)
N A P-value N A N A P-value
FZD1 6/8 5/8 0.5 2/5 6/11 62 58 1
FZD2 7/8 1/8 0.015 3/5 3/11 77 21 0.003
FZD3 1/8 6/8 0.03 1/5 7/11 15 68 0.005
FZD4 0/8 2/8 0.25 0/5 4/11 0 32 0.06
FZD5 7/12 6/12 0.5 ND ND 58 50 1
FZD6 2/8 4/8 0.25 1/5 8/11 23 63 0.04
FZD7 7/12 7/12 0.6 ND ND 58 58 1
FZD8 7/8 2/7 0.063 5/5 3/11 92 26 0.007
FZD10 1/8 2/8 0.475 0/5 5/11 8 37 0.1
ND¼not performed.
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sb-Catenin stabilisation
Although most colorectal tumours harbour APC mutations, some
develop through alternative routes (Morin et al, 1997). We stained
paraffin sections of the series of 14 adenomas analysed previously
to identify nuclear b-catenin and identified this in all but two cases
(M and N). These were the same individuals that lacked induction
of NKD1, FZD3 and FZD6 mRNAs, indicating that unregulated
b-catenin signalling is required to induce these transcripts.
Signalling in adenomas
Signalling outcomes of b-catenin-independent Wnt pathways in
human epithelia have yet to be defined. The Wnt/Ca
2þ pathway
can lead to a range of outcomes, some of which, such as changes in
cytosolic calcium levels, cannot be measured in adenoma biopsies.
Wnt/PCP signalling, however, invariably involves JNK activation.
We investigated the presence of nuclear phosphorylated c-Jun, as a
marker of this activity, in paraffin sections of the adenomas used
previously for RNA analysis, and examples of this are shown in
Figure 3. All but one of the adenomas contained nuclear phospho-
c-Jun. This exception was one of the two adenomas where
b-catenin was not seen in the nucleus, which also contained low
levels of NKD1, these data are summarised in Figure 2.
Induction of NKD1 and FZD3 in cultured cells
The correlation between NKD1, FZD3 and FZD6 and b-catenin
stabilisation indicates a cell autonomous effect in the tumour
epithelium. In the absence of reliable reagents to assess this in
histological sections, we attempted to recapitulate these events
in vitro. Previous experiments (Yan et al, 2001) demonstrated
b-catenin dependence of NKD1 transcription. Stabilisation of
b-catenin in cultured cells would determine whether the FZD
expression changes are cell autonomous. The epithelial cell line
Fhs74Int, which was isolated from normal intestine (Owens et al,
1976) and retains normal APC function, was used for these
experiments. We treated confluent cultures with lithium chloride,
an inhibitor of glycogen synthase kinase-3b (GSK-3b), to stabilise
b-catenin (Klein and Melton, 1996), and measured changes in
NKD1 and FZD3. Figure 4A shows that NKD1 levels increased
substantially, reaching a peak after 8h and dropping gradually
towards 16h after induction, while FZD3 levels were essentially
unaffected by lithium treatment, indicating that b-catenin
stabilisation alone cannot account for the induction of FZD3
observed in adenomas.
In a separate experiment, shown in Figure 4B, HeLa cells, which
have intact APC and normal b-catenin levels, were treated with
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Figure 2 Real-time RT–PCR analysis of NKD1, FZD3 and FZD6
expression in colorectal adenomas. Relative expression of NKD1 (open
bars), FZD3 (grey bars) and FZD6 (striped bars) was determined in a series
of adenomas by comparison to their levels in matched normal samples,
using real-time RT–PCR as described in the text. Samples were ordered by
NKD1 expression levels to reveal any association between the targets.
Note that two samples (E and N) were not analysed for FZD6. These
adenomas were also stained to assess nuclear accumulation of b-catenin
and phospho-c-Jun and the outcome of this is indicated below each cluster
of bars where þ indicates detection and   indicates a failure to detect
nuclear b-catenin (C) and phospho-c-Jun (J).
Figure 3 Immunohistochemical detection of b-catenin and phospho-c-
Jun in colorectal adenomas. Paraffin sections of fixed adenoma tissue were
stained to detect phospho-c-Jun (A and B) and b-catenin (C and D).
Representative samples are shown. Positive nuclear localisation was
detected in sample (B), shown by the arrow (A and C), whereas in
sample M (B and D) the arrow indicates the absence of nuclear
accumulation.
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Figure 4 Induction of NKD1 and FZD3 in cultured cells. (A) Lithium
chloride induction of NKD1 mRNA in FHs74Int cells. Confluent cells were
treated with lithium chloride and sampled over a 16-h time course.
Expression of FZD3 and NKD1 was measured by real-time RT–PCR and
the level relative to untreated control cells determined. The inset panel
shows qualitative RT–PCR analysis of the induced cells at 0 and 16h. (B)
Wnt3a induction of NKD1 and FZD3 mRNA in HeLa cells. Confluent cells
were treated with Wnt3a-conditioned medium and sampled over a 17-h
time course. Expression of NKD1 and FZD3 was measured by real-time
RT–PCR and the level relative to untreated control cells determined.
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mouse L-cells. In this case, NKD1 levels continued to rise over the
17h time course of the experiment, while FZD3 expression was
maximal after 4h of treatment. In both cases, the levels of
induction reached were comparable with those seen in our
previous analysis of adenomas.
Expression in cancers
To determine whether this induction pattern is sustained through-
out tumorigenesis, we performed real-time RT–PCR analysis of
NKD1 and FZD3 in a series of 23 colorectal cancers. Figure 5 shows
that while NKD1 was induced in the majority (20 out of 23) of
cancers compared with matched normal tissue, the median level of
induction (7.4-fold) was substantially lower than the 135-fold we
saw in adenomas. The pattern of FZD3 induction was also markedly
different in cancers, with only 40% (9 out of 23) showing significant
induction, 30% (7 out of 23) essentially unchanged and the
remaining 30% (7 out of 23) downregulated. In addition, there
was no clear relationship between NKD1 and FZD3 induction,
contrasting with the expression profiles seen in adenomas.
DISCUSSION
Our data show that NKD1, FZD3 and FZD6, key determinants of
the b-catenin-independent Wnt response pathways, are induced
early in colorectal tumorigenesis, coinciding with the loss of Wnt
antagonists such as sFRP1 (Caldwell et al, 2006). As adenomas
progress into cancers, NKD1 expression reduces and its relation-
ship with FZDs3 and 6 levels is lost. In vitro experiments indicated
that while NKD1 induction is a direct result of b-catenin signalling,
FZD3 expression requires a Wnt growth factor signal. This
indicates that Wnt/Ca
2þ receptor expression in tumours occurs
in response to the unmodulated Wnt signal that results from Wnt
antagonist downregulation.
A previous study (Yan et al, 2001) showed NKD1 expression in
colorectal cancer and regulation by b-catenin in vitro, but our
study is the first to examine its expression in adenomas and
quantify the degree of induction. The extent of upregulation we
found in adenomas (median 135-fold) was striking and indicates
that incoming signals from Wnt growth factors would be directed
towards the Wnt/PCP response in these tumours. Our demonstra-
tion of c-Jun activation in adenomas supports this. The
importance of c-Jun in colorectal adenoma formation, through
its interaction with b-catenin and TCF4, has been demonstrated in
animal models (Nateri et al, 2005), but Wnt/PCP signalling is not
the only route to c-Jun activation and its contribution to this in
adenomas warrants further investigation.
The median level of NKD1 induction in cancers (7.4-fold) was
substantially lower than the 135-fold we saw in adenomas. The
reason for the difference observed between the degree of change
seen in adenomas and in cancers is not entirely clear. The many
differences between adenomas and cancers may lead to a reduction
in dependence on these reorganised Wnt pathways as the disease
progresses. Although genetic changes (e.g. APC mutations) cannot
be reversed during tumour progression, other effects may show
plasticity when selection pressure is lost due to mutations in
other pathways. To explore this, we shall first have to define
the outcomes of b-catenin-independent Wnt signalling in the
adenoma.
The potential for Wnt/Ca
2þ signalling to have a role in early
colorectal tumorigenesis is presently unclear. Signalling in this
pathway has been associated with the progression in some
tumours (Huang et al, 2005; Kurayoshi et al, 2006; Ripka et al,
2007) and suppression in others (Liang et al, 2003; Blanc et al,
2005; Dejmek et al, 2005; Kremenevskaja et al, 2005), so any
contribution it makes to tumorigenesis may depend on other
factors in the tissue.
One disadvantage of studying these events in adenomas is the
scarcity of material available, which limits the number of parallel
analyses that can be performed on a single sample. For this reason,
we have chosen not to explore Wnt/Ca
2þ signalling outcomes in
this cohort until we can identify unambiguous markers of a
response. Studies in more tractable systems have shown that
Wnt5a and Wnt11 action leads to a loss of cell adhesion, stimulates
PKC and CamKII, and antagonises the b-catenin pathway (Torres
et al, 1996). Ca
2þ-dependent PKC isoforms are present in
colorectal adenomas, but are less abundant in proliferating areas
(Kahl-Rainer et al, 1996), so it is unlikely that a simple relationship
exists between Wnt/Ca
2þ signalling through PKC and prolifera-
tion of adenoma cells. Studies with purified Wnt5a indicated that
calcium release is not a universal outcome of signalling, but
demonstrated receptor-dependent antagonism of b-catenin’s
transcriptional activity in the presence of the ROR2 co-receptor
(Mikels and Nusse, 2006) emphasising the impact of the receptor
context on signalling outcomes. We investigated the expression
of ROR2 in our tumours but found no consistent pattern of
expression, with as many cases showing downregulation
as increased expression (data not shown). Since unregulated
b-catenin-dependent transcription is a hallmark of colorectal
tumours, b-catenin antagonism must be incomplete.
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Figure 5 Real-time RT–PCR analysis of NKD1 and FZD3 expression in colorectal cancers. Relative expression of NKD1 (open bars) and FZD3 (filled
bars) was determined in a series of colorectal cancers by comparison to matched normal samples, using real-time RT–PCR as described in the text. Samples
were ordered by NKD1 levels for comparison between the two series.
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treatment led to NKD1 expression but failed to influence Wnt/
Ca
2þ receptors, while Wnt growth factor treatment induced FZD3
transcripts to the degree seen in adenomas. In early tumorigenesis,
Wnt signalling is enhanced relative to normal epithelium as a
result of antagonist suppression, and this is likely to be the origin
of the elevated FZDs3 and 6 expression we identified in adenomas.
In normal cells, NDK1 and FZD3/6 are expressed transiently to
repress further b-catenin stabilisation providing a negative feed-
back to Wnt stimulation. In tumour cells lacking APC function,
this homoeostatic loop fails to complete, leading to sustained
expression and establishment of alternative Wnt-response
pathways. The epigenetic suppression of secreted Wnt antagonists
seen in adenomas (Caldwell et al, 2006) and the sensitivity of
tumour cells to Wnt restriction (DeAlmeida et al, 2007) indicate an
enduring requirement for Wnt ligand signals, which will lead to
responses in the pathways induced. This may have a number of
consequences, such as stimulation of MAP kinase signalling by
mobilising EGF ligands (Kim and Choi, 2007; Schlange et al, 2007).
The high levels of b-catenin-independent Wnt-response path-
way components we have shown distinguish early tumour cells
from normal tissue. These early tumours are potentially unstable
and susceptible to regression. If b-catenin-independent Wnt
signalling is shown to contribute to progression, blockade of these
events may provide a novel approach to preventing cancer
development.
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